HIV Postexposure Prophylaxis Algorithm: Sexual Assault
Criteria for recommending postexposure prophylaxis (PEP) to HIV following sexual assault
Criteria for recommending postexposure prophylaxis (PEP) to HIV following sexual assault
The COVID-19 pandemic and opioid crisis created new barriers to HCV treatment, leading to the lowest annual treatment rate in 5 years.
Previously, the vaccine was only approved for adults 50 years of age and older.
The authors present seven cases of acute myocarditis or myopericarditis in healthy male adolescents within four days of receiving the second dose of the Pfizer-BioNTech COVID-19 vaccination.
SB206 is an investigational nitric oxide-releasing topical gel that contains berdazimer sodium plus a hydrogel.
Whether oral vitamin D supplementation in patients who are vitamin D deficient would result in wart clearance was investigated.
The study authors established an international registry for COVID-19-related dermatologic symptoms in April 2020.
The cutaneous signs thus reported as COVID-19 related, their incidence, clinic-pathologic features, and diagnostic and prognostic values are described.
The American Society for Dermatologic Surgery (ASDS) has released a new guidance regarding adverse events associated with the SARS-CoV-2 mRNA vaccine and dermal fillers.
Findings of a recently updated systematic review support the World Health Organization’s (WHO) recommendation that children infected with HIV should be revaccinated against measles following immune reconstitution with combination antiretroviral therapy (cART).